Rockefeller Capital Management L.P. Amgen Inc Transaction History

Rockefeller Capital Management L.P.

$33.9 Billion
Q1 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Amgen Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 432,971 shares of AMGN stock, worth $135 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

432,971

Previous 616,520 29.77%

Holding current value

$135 Million

Previous $178 Million 30.67%

% of portfolio

0.36%

Previous 0.6%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $49.4 Million - $59.6 Million	-183,549 Reduced 29.77%	432,971 $123 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $28.5 Million - $32.1 Million	111,373 Added 22.05%	616,520 $178 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $51.9 Million - $64.4 Million	237,408 Added 88.67%	505,147 $136 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.42 Million - $1.68 Million	6,634 Added 2.54%	267,739 $59.4 Million
Q1 2023 May 17, 2023	SELL	$225.79 - $275.2 $3.42 Million - $4.17 Million	-15,150 Reduced 5.48%	261,105 $63.1 Million

Q4 2022 Mar 06, 2023	SELL	$229.03 - $291.01 $1.73 Million - $2.2 Million	-7,570 Reduced 2.67%	276,255 $72.6 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $17.5 Million - $19.8 Million	78,035 Added 37.92%	283,825 $64 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $2.4 Million - $2.67 Million	10,402 Added 5.32%	205,790 $50.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $4.06 Million - $4.49 Million	18,500 Added 10.46%	195,388 $47.2 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $4.12 Million - $4.71 Million	20,704 Added 13.26%	176,888 $39.8 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $3.46 Million - $4.05 Million	16,291 Added 11.65%	156,184 $33.2 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $3.62 Million - $4.02 Million	15,496 Added 12.46%	139,893 $34.1 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $2.71 Million - $3.16 Million	12,204 Added 10.88%	124,397 $31 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $5.61 Million - $6.68 Million	25,935 Added 30.07%	112,193 $25.8 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $2.4 Million - $2.67 Million	10,240 Added 13.47%	86,258 $21.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $722,797 - $886,971	3,654 Added 5.05%	76,018 $17.9 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $1.25 Million - $1.66 Million	6,861 Added 10.47%	72,364 $14.7 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $5.6 Million - $7.2 Million	29,622 Added 82.56%	65,503 $15.8 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.98 Million - $2.37 Million	11,382 Added 46.46%	35,881 $6.94 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $1.72 Million - $2.02 Million	10,336 Added 72.98%	24,499 $4.52 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $2.24 Million - $2.53 Million	12,396 Added 701.53%	14,163 $2.69 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 3.51%	1,767 $345,000
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $2,490 - $2,797	15 Added 0.89%	1,707 $315,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $286,675 - $335,016	1,692 New	1,692 $289,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Amgen Inc Transaction History